Neuromodulation System and Method For Treating Apnea

• US 20120253249A1
• Filed: 05/16/2011
• Published: 10/04/2012
• Est. Priority Date: 03/28/2011
• Status: Active Grant

• Current Assignee: Med El Elektromedizinische Geraete GmbH, Neurostream Technologies G.P.
• Original Assignee: Med El Elektromedizinische Geraete GmbH
• Inventors: Wilson, Willard
• Granted Patent: US 8,644,921 B2
• Time in Patent Office: Days
• US Class Current: 601/154
• CPC Class Codes: A61B 5/02055 Simultaneously evaluating both cardiovascular condition and temperature
• CPC Class Codes: A61B 5/0816 Measuring devices for examining respiratory frequency measuring frequency of electric signals G01R23/00
• CPC Class Codes: A61B 5/087 Measuring breath flow
• CPC Class Codes: A61B 5/113 occurring during breathing
• CPC Class Codes: A61B 5/14542 for measuring blood gases A61B5/14551 takes precedence
• CPC Class Codes: A61B 5/24 Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
• CPC Class Codes: A61B 5/389 Electromyography [EMG]
• CPC Class Codes: A61B 5/4818 Sleep apnoea
• CPC Class Codes: A61H 21/00 Massage devices for cavities of the body , e.g. nose, ears and anus for the genitals A61H19/00; Vibration or percussion related aspects A61H23/00
• CPC Class Codes: A61H 2205/02 Head
• CPC Class Codes: A61H 2230/206 used as a control parameter for the apparatus
• CPC Class Codes: A61H 2230/208 used as a control parameter for the apparatus
• CPC Class Codes: A61H 2230/255 used as a control parameter for the apparatus
• CPC Class Codes: A61H 2230/405 used as a control parameter for the apparatus
• CPC Class Codes: A61H 2230/605 used as a control parameter for the apparatus
• CPC Class Codes: A61H 9/0007 Pulsating
• CPC Class Codes: A61H 9/0021 Hydraulic massage
• CPC Class Codes: A61N 1/0548 Oral electrodes
• CPC Class Codes: A61N 1/0556 Cuff electrodes
• CPC Class Codes: A61N 1/3601 of respiratory organs
• CPC Class Codes: A61N 1/36057 : adapted for stimulating afferent nerves
• CPC Class Codes: A61N 1/3611 : Respiration control stimulating respiratory organs A61N1/3601
• CPC Class Codes: A61N 1/36157 : Current A61N1/3616 takes precedence
• CPC Class Codes: A61N 1/36171 : Frequency
• CPC Class Codes: A61N 1/36178 : Burst or pulse train parameters

Abstract

The present disclosure provides systems and methods for treating apnea by controlled delivery of a swallow stimulus to a subject in which apnea is detected. In the systems and method, burst electrical or mechanical stimulation to one or more swallow-related nerves and/or muscles can be timed for delivery between the expiratory phase of the respiration cycle, following detection of an apneic event in the subject.

Claims

1. A system for treating apnea in a subject, comprising:

a) an electrode configured for positioning in contact with the internal branch of the superior laryngeal nerve (iSLN) of the subject.

b) a control unit comprising;

i. a signal conditioning module for conditioning an electroneurogram signal from the electrode;

ii. an apnea monitoring and detection module operatively coupled to the signal conditioning module and configured for computing an index of respiratory activity from the conditioned electroneurogram signal, wherein when the index of respiratory activity is at or above a predetermined level, the index of respiratory activity is indicative of an occurrence of an apneic event; and

iii. a therapy control module operatively coupled to the apnea monitoring and detection module and configured to control delivery of a swallow stimulus to the subject when the index of respiratory activity is indicative of an occurrence of an apneic event.

2. The system of claim 1, wherein the swallow stimulus is at least one of:

electrical stimulation to at least one swallow-related nerve, electrical stimulation to at least one swallow-related muscle, and mechanical stimulation to at least one swallow-related sensory receptor.

3. The system of claim 1, wherein the swallow stimulus comprises a burst of electrical stimulation or a burst of mechanical stimulation.

4. The system of claim 2, wherein the swallow stimulus comprises mechanical stimulation to at least one swallow-related sensory receptor comprising delivery of a liquid to at least one of the oral, nasal, or pharyngeal cavity of the subject.

5. The system of claim 2, further comprising:

a) a stimulation module operatively connected to the therapy control module; and

b) a stimulation output device coupled to the stimulation module and configured for delivery of the swallow stimulus to the subject, wherein the stimulation module is configured to generate the swallow stimulus through the stimulation output device.

6. The system of claim 5, wherein the stimulation output device comprises a stimulation electrode coupled to the stimulation module and configured for positioning in contact with at least one swallow-related nerve or muscle, wherein the stimulation module is configured to generate electrical stimulation through the stimulation electrode to at least one swallow-related nerve or muscle.

7. The system of claim 6, wherein the therapy control module is configured to activate bursts of electrical stimulation to at least one swallow-related nerve or muscle.

8. The system of claim 5, wherein the stimulation output device comprises a mechanical stimulation delivery device configured to generate mechanical stimulation and deliver the stimulation to at least one swallow-related sensory receptor in the skin or mucosa of the subject.

9. The system of claim 8, wherein the mechanical stimulation delivery device is configured for delivery of a liquid to the oral, nasal, or pharyngeal cavity of the subject.

10. The system of claim 9, wherein the therapy control module is configured to activate bursts of mechanical stimulation to the subject.

11. The system of any of any of claims 1-3, wherein the apnea monitoring and detection module is further configured to detect an apnea.

12. The system of any of claims 1-3, wherein the index of respiratory activity is indicative of at least one of upper airway pressure, airway stretch, and airway temperature.

13. The system of claim any of claim 12, wherein the index of respiratory activity is indicative of upper airway pressure.

14. The system of any of claims 1-3, wherein the index of respiratory activity is further indicative of the respiratory phase in the subject over time, wherein the respiratory phase comprises at least one of an inspiratory phase, an expiratory phase and a zero flow phase.

15. The system of claim 14, wherein the index of respiratory activity is indicative of respiratory phase, and the therapy control module is further configured to synchronize delivery of burst mechanical stimulation, to at least one swallow-related sensory receptor in the skin or mucosa of the subject between inspiratory phases of the subject, the burst stimulation sufficient to elicit sufficient to elicit all or part of a swallow sequence in the subject.

16. The system of claim 14, wherein the index of respiratory activity is indicative of respiratory phase, and the therapy control module is further configured to synchronize delivery of burst electrical stimulation, to at least one swallow-related muscle between inspiratory phases of the subject, the burst stimulation sufficient to elicit sufficient to elicit all or part of a swallow sequence in the subject.

17. The system of claim 14, wherein the index of respiratory activity is indicative of respiratory phase, and the therapy control module is further configured to synchronize delivery of burst electrical stimulation to at least one swallow-related nerve between inspiratory phases, the burst stimulation sufficient to elicit sufficient to elicit all or part of a swallow sequence in the subject.

18. The system of claim 17, wherein the swallow-related nerve is an afferent nerve or an efferent nerve.

19. The system of claim 17, wherein the swallow-related nerve is an afferent nerve, wherein stimulation of the afferent nerve triggers swallow reflexive pattern activity in the central nervous system of the subject that is sufficient to elicit all or part of a swallow sequence by the subject.

20. The system of claim 2, wherein the swallow-related nerve is the superior laryngeal nerve (SLN).

21. The system of claim 2, wherein the swallow-related nerve the internal branch of the superior laryngeal nerve.

22. The system of claim 2, wherein the swallow-related nerve is the glossopharyngeal nerve.

23. The system of claim 2, wherein the swallow-related nerve is the pharyngeal branch of the glossopharyngeal nerve.

24. The system of claim 2, wherein the swallow-related nerve is an efferent nerve, wherein stimulation of the efferent nerve elicits motor activity in at least one effector of a swallow response in the subject, the motor activity comprising all or part of a swallow sequence by the subject.

25. The system of claim 3, wherein the apnea monitoring and detection module is further configured to compare the index of respiratory activity following delivery of each burst of stimulation, to a predetermined recovery threshold and thereby detect recovery from apnea in response to each burst of stimulation.

26. The system of claim 25, wherein the therapy control module is further configured to repeat delivery of burst stimulation when recovery from apnea is not detected.

27. The system of any of claims 1-10, wherein the system is partially or fully implantable.

28. A method for treating apnea, the method comprising:

a) sensing a respiratory signal in a subject;

b) detecting apnea based on the respiratory signal;

c) when apnea is detected, triggering the delivery of a swallow stimulus sufficient to elicit all or part of a swallow in the subject; and

d) optionally repeating steps (a) through (c).

29. The method of claim 28, wherein the swallow stimulus comprises at least one of:

electrical stimulation to at least one swallow-related nerve, electrical stimulation to at least one swallow-related muscle, and mechanical stimulation to at least one swallow-related sensory receptor in the skin or mucosa of the subject, the swallow stimulus sufficient to elicit all or part of a swallow sequence in the subject.

30. The method of claim 29, wherein the swallow stimulus comprises burst electrical stimulation or burst mechanical stimulation.

31. The method of claim 29, wherein the swallow stimulus comprises mechanical stimulation to at least one swallow-related sensory receptor, comprising delivery of a liquid to at least one of the oral, nasal, or pharyngeal cavity of the subject.

32. The method of claim 29, wherein the swallow stimulus comprises electrical stimulation to at least one swallow-related nerve or muscle.

33. The method of claim 30, wherein the respiratory signal further comprises a signal indicative of respiratory phase in the subject over time, wherein the respiratory phase comprises at least one of an inspiratory phase, an expiratory phase and a zero flow phase.

34. The method of claim 33, wherein the triggering of the electrical burst stimulation or mechanical burst stimulation comprises synchronizing the delivery of the burst stimulation between inspiratory phases of the subject.

35. The method of claim 28, further comprising computing an index of respiratory activity indicative of at least one of upper airway pressure, airway stretch, and airway temperature.

36. The method of claim 35, wherein the index of respiratory activity is indicative of upper airway pressure.

37. A method for treating sleep apnea, the method comprising:

a) recording an electroneurogram signal from the internal branch of the superior laryngeal nerve (iSLN) of the subject;

b) conditioning the electroneurogram signal;

c) computing an index of respiratory activity from the conditioned electroneurogram signal;

d) reporting an occurrence of an apneic event when the index of respiratory activity is at or above a predetermined level; and

e) upon occurrence of an apneic event, triggering delivery of a swallow stimulus to the subject, wherein the swallow stimulus is sufficient to elicit all or part of a swallow sequence in the subject.

38. The method of claim 37, wherein the swallow stimulus comprises at least one of:

electrical stimulation to at least one swallow-related nerve, electrical stimulation to at least one swallow-related muscle, and mechanical stimulation to at least one swallow-related sensory receptor in the skin or mucosa of the subject.

39. The method of claim 38, wherein the swallow stimulus comprises burst electrical stimulation or burst mechanical stimulation.

40. The method of claim 38, wherein the swallow stimulus comprises mechanical stimulation to at least one swallow-related sensory receptor, comprising delivery of a liquid to at least one of the oral, nasal, or pharyngeal cavity of the subject.

41. The method of claim 38, wherein the swallow stimulus comprises electrical stimulation to at least one swallow-related swallow-related nerve or muscle.

42. The method of claim 41, comprising electrical stimulation to at least two swallow-related nerves, at least two swallow-related muscles, or at least a swallow-related nerve and a swallow-related muscle.

43. The method of claim 39, wherein the respiratory signal further comprises a signal indicative of respiratory phase in the subject over time, wherein the respiratory phase comprises at least one of an inspiratory phase, an expiratory phase and a zero flow phase.

44. The method of claim 43, wherein the respiratory signal is indicative of respiratory phase in the subject over time, and the triggering of the electrical burst stimulation or mechanical burst stimulation comprises synchronizing the delivery of the burst stimulation between inspiratory phases of the subject.

45. The method of claim 39, wherein the index of respiratory activity is indicative of at least one of upper airway pressure, airway stretch, and airway temperature.

46. The method of claim 45, wherein the index of respiratory activity is indicative of upper airway pressure.

47. The method of claim 43, wherein the swallow stimulus comprises burst electrical stimulation to at least one swallow-related nerve wherein a swallow-related nerve is an afferent nerve or an efferent nerve.

48. The method of claim 47, comprising burst electrical stimulation to at least two swallow-related nerves wherein each swallow-related nerve is independently an afferent nerve or an efferent nerve.

49. The method of claim 41, wherein the swallow-related nerve is an afferent nerve, wherein stimulation of the afferent nerve elicits swallow reflexive pattern activity from the central nervous system of the subject sufficient to elicit all or part of a swallow sequence in the subject.

50. The method of claim 38, wherein the swallow-related nerve is the internal branch of the superior laryngeal nerve (iSLN).

51. The method of claim 38, wherein the swallow-related nerve is the pharyngeal branch of the glossopharyngeal nerve.

52. The method of claim 38, wherein the swallow-related nerve is an efferent nerve, wherein stimulation of the efferent nerve elicits motor activity in at least one effector in a swallow sequence, the motor activity comprising all or part of a swallow sequence in the subject.

53. The method of any of claims 39-52, further comprising comparing the electroneurogram signal following delivery of each burst of stimulation, to a predetermined recovery threshold and thereby detecting recovery from apnea in response to each burst of stimulation.

54. The method of claim 53, further comprising repeating a burst of stimulation when recovery from apnea is not detected.

55. The method of any of claims 39 and 41-53, wherein delivering electrical stimulation comprises delivering a burst of stimulus pulses having a frequency of at least about 20 Hz to about 40 Hz, wherein each pulse has an amplitude of greater than about 0.1 mA and a duration of about 200 μ

sec.

56. A device for treating apnea in a subject, comprising:

a) an electrode configured for positioning in contact with the internal branch of the superior laryngeal nerve (iSLN) of the subject, further configured for obtaining an electroneurogram signal from the iSLN and for delivering electrical stimulation to the iSLN;

b) a control unit comprising;

i. a signal conditioning module for conditioning the electroneurogram signal from the electrode; and

ii. an apnea monitoring and detection module operatively coupled to the signal conditioning module and configured for computing an index of respiratory activity from the conditioned electroneurogram signal, wherein when the index of respiratory activity is at or above a predetermined level, the index of respiratory activity is indicative of an occurrence of an apneic event;

iii. a therapy control module wherein the therapy control module is configured to control delivery of a swallow stimulus, wherein delivery of the swallow stimulus is triggered when the index of respiratory activity is indicative of an occurrence of an apneic event.

57. The device of claim 56, wherein the therapy control module is configured to control delivery of electrical stimulation through the electrode to at least one swallow-related nerve when the index of respiratory activity is indicative of an occurrence of an apneic event.

58. The device of claim 56, wherein the control unit? comprises a respiratory phase module configured to determine respiratory phase from the index of respiratory activity and to generate a respiratory phase signal from the subject.

59. The device of claim 58, wherein the therapy control module is further configured to activate burst stimulation of the iSLN between inspiratory phases based on the respiratory phase signal, the burst stimulation sufficient to produce all or part of a swallow sequence in the subject.

60. The device of claim 59, wherein the electrode and therapy control module are implantable.

61. The device of claim 56 further comprising a stimulus output device configured for oral, nasal or pharyngeal delivery of a liquid to the subject and operatively coupled to the therapy control module, wherein the therapy control module is further configured to activate oral, nasal or pharyngeal delivery of liquid to the subject when the index of respiratory activity is indicative of an occurrence of an apneic event.

62. A method for treating dysphagia, the method comprising:

a) sensing a dysphagia signal in a subject;

b) detecting dysphagia based on the dysphagia signal;

c) when dysphagia is detected, triggering the delivery of a swallow stimulus sufficient to elicit all or part of a swallow in the subject; and

d) optionally repeating steps (a)-(c).

63. The method of claim 62, wherein the swallow stimulus comprises at least one of:

electrical stimulation to at least one swallow-related nerve, electrical stimulation to at least one swallow-related muscle, and mechanical stimulation to at least one swallow-related sensory receptor in the skin or mucosa of the subject.

64. The method of claim 62, wherein the swallow stimulus comprises burst electrical stimulation or burst mechanical stimulation.

65. The method of claim 62, further comprising sensing a respiratory signal, wherein the respiratory signal is indicative of respiratory phase, wherein the respiratory phase is either an inspiratory phase, an expiratory phase, or a zero flow phase and the triggering of the burst stimulation comprises synchronizing the delivery of the burst stimulation between inspiratory phases of the subject.

66. The method of claim 62, wherein the swallow stimulus comprises mechanical stimulation to at least one swallow-related sensory receptor, comprising delivery of a liquid to at least one of the oral, nasal, or pharyngeal cavity of the subject.

67. The method of claim 62, wherein the swallow stimulus comprises electrical stimulation to at least one swallow-related nerve or muscle.